Billionaire David Einhorn spent most of 2024 warning investors about how overvalued stocks were. In early 2025, the hedge ...

DexCom's growth is slowing with 2024 marking the slowest growth year in a decade and 2025 expected to follow suit with ~14% ...

Ocular Therapeutix Q4 2024 earnings reveal FDA-approved trial updates for AXPAXLI in wet AMD, streamlined designs, and strong cash reserves.

Semiconductor wafer inspection equipment market is experiencing growth and is expected to reach a value of USD 15.75 billion ...

On track to achieving its target of a 9-10% investment growth this year, the Philippine Economic Zone Authority (PEZA) recorded an outstanding PhP 52.933 billion in investments following the board ...